Symrise enhances its health and wellness portfolio through the acquisition of Probi, focusing on innovative solutions for human and pet health.
Target Information
Symrise, a global leader in the flavor and nutrition industry, is strategically enhancing its portfolio by integrating Probi, a renowned provider of clinically proven biotic solutions. This acquisition is set to strengthen Symrise's commitment to health and wellness, particularly in the sectors of human and pet health. The announcement coincides with Symrise's participation at Vitafoods Europe 2025, where it will showcase innovative health solutions focused on healthy aging, joint health, and urinary health.
Symrise aims to deliver science-backed, nature-sourced health active solutions that address both consumer needs and industry trends. By incorporating Probi's expertise, Symrise can enhance its offerings with clinically validated biotic solutions.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The health and wellness industry is witnessing significant growth globally, driven by an increasing consumer awareness of the importance of nutrition in overall healt
Similar Deals
Teleflex Incorporated → Vaskuläre Intervention (VI) business unit of BIOTRONIK
2025
Symrise
invested in
Probi
in 2025
in a Merger deal